SPARC Site 42 — Alexandria, Louisiana

SPARC Site 42 is a clinical research site located in Alexandria, Louisiana, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

SPARC Site 42 has participated in 1 clinical trials.

Therapeutic areas: Spasticity.

Sponsors: Sun Pharma Advanced Research Company Limited.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Alexandria

Browse all research sites in Louisiana · View every site in Alexandria

• Christus St. Frances Cabrini Hospital
• Cabrini Center for Cancer Care at Christus St. Frances Cabrini Hospital
• CHRISTUS St. Frances Cabrini Hospital Center for Cancer Care ( Site 0109)
• Cabrini Center for Cancer Care/Christus St. Frances Cabrini Hospital
• Christus Saint Frances Cabrini Hospital
• Christus Saint Frances, Cabrini Hospital, Cabrini Cancer Center
• Tulane Cancer Center Office of Clinical Research
• Research Site
• Alexandria Cardiology Clinic
• Cambridge Medical Trials
• Novartis Investigative Site
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SPARC Site 42?

SPARC Site 42 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SPARC Site 42 conducted?

SPARC Site 42 has 1 clinical trials on record. Their work covers Spasticity.

Is SPARC Site 42 accredited by Crixeo Clinical Trials?

SPARC Site 42 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SPARC Site 42?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.